Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant Tamoxifen mono-therapy: a DBCG study

Creators
Not specifiedAdditional credit
Lyng MB, Lænkholm A, Søkilde R, Gravgaard KH, LItman T, Ditzel HJ
Submitter
Views: 912
Created: 22nd Feb 2022 at 09:56

This item has not yet been tagged.

None
Version History
Version 1 (earliest) Created 22nd Feb 2022 at 09:56 by Olga Krebs
No revision comments